nitroglycerin
| Drug Name | Form | Strength | Notes |
|---|---|---|---|
| Nitroglycerin ER | CAPSULE, EXTENDED RELEASE, ORAL | 2.5 mg | |
| Nitroglycerin ER | CAPSULE, EXTENDED RELEASE, ORAL | 6.5 mg | |
| Nitroglycerin ER | CAPSULE, EXTENDED RELEASE, ORAL | 9 mg | |
| Nitroglycerin Transdermal System | FILM, EXTENDED RELEASE, TRANSDERMAL | 0.1 mg/hr | |
| Nitroglycerin Transdermal System | FILM, EXTENDED RELEASE, TRANSDERMAL | 0.2 mg/hr | |
| Nitro-Dur | FILM, EXTENDED RELEASE, TRANSDERMAL | 0.3 mg/hr | |
| Nitroglycerin Transdermal System | FILM, EXTENDED RELEASE, TRANSDERMAL | 0.4 mg/hr | |
| Nitroglycerin Transdermal System | FILM, EXTENDED RELEASE, TRANSDERMAL | 0.6 mg/hr | |
| Nitro-Dur | FILM, EXTENDED RELEASE, TRANSDERMAL | 0.8 mg/hr | |
| Nitro-Bid | OINTMENT, TRANSDERMAL | 2% | |
| Nitroglycerin | SOLUTION, INTRAVENOUS | 5 mg/mL | |
| Nitroglycerin | SOLUTION, INTRAVENOUS | 100 mcg/mL-D5% | |
| Nitroglycerin | SOLUTION, INTRAVENOUS | 200 mcg/mL-D5% | |
| Nitroglycerin | SOLUTION, INTRAVENOUS | 400 mcg/mL-D5% | |
| Nitrolingual | SPRAY, SUBLINGUAL | 0.4 mg | |
| Nitrostat | TABLET, SUBLINGUAL | 0.4 mg |
For Titration Guidelines See Policy 900.3028
Patch Specific Pharmaceutical Waste Guide: See Protocol 900.4412
2% ointment - for use in treatment of extravasation: please refer to Elsevier Clinical Skills: Prevention and Management of Extravasations for the Treatment and Management of Extravasations.